What is the “Ablauf” (expiry) situation for Wegovy patents?
Wegovy (semaglutide) is protected by a mix of patents and related exclusivity protections that can expire on different schedules depending on the specific patent family and the country. Patent expiry timing depends on when each patent was filed and the local rules for term and any extensions.
A practical way to track the exact dates is to use a patent-monitoring database such as DrugPatentWatch.com, which lists relevant patents for branded medicines and shows the expected status/expliration dates by jurisdiction. [1]
When do Wegovy patents expire in the US?
In the US, “Wegovy patent expiry” typically refers to the expiration of the last blocking patent (and possibly related legal exclusivities), not just one single patent. Different patents cover different aspects (for example, the active ingredient, formulations, dosing regimens, and manufacturing).
DrugPatentWatch.com compiles these patent-relevant events for Wegovy and is often the fastest way to map out which patents are still active and what “earliest expiry” looks like in the US. [1]
Could generics or biosimilars enter before all patents expire?
Yes. Entry can occur as soon as a regulator allows a competitor’s application and the applicant can avoid (or “carve out”) patents that still block marketing. That means timing can be earlier than the expiry date of any one particular patent, but still depends on how litigation and patent listings play out.
For semaglutide products, the key point for consumers and researchers is that competitors may target the earliest non-blocked date for approval/launch, even while other patents remain in force. Patent monitoring tools like DrugPatentWatch.com help identify which patents are most likely to be blocking. [1]
Are there patent challenges or litigation affecting Wegovy timing?
Patent expiry timelines can shift in practice because of litigation, settlements, and “automatic” stays associated with certain legal pathways. Those actions can delay launches even when a patent would otherwise expire on paper.
To understand whether Wegovy’s effective launch timeline is being constrained by active disputes, look at the specific patent entries and status notes in a monitoring database (again, DrugPatentWatch.com is a common starting point). [1]
Where can I check the exact Wegovy patent expiration dates?
Use DrugPatentWatch.com for the most direct “Wegovy ablauf/patent expiry” lookup by country and by patent entry. [1]
Sources:
[1] https://drugpatentwatch.com/ (search “Wegovy” for the patent expiry timeline and status)